Biglycan (December 2011) Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University Posted on December 28, 2011 Research & Clinical Trial Webinars, Webinars Facebook Twitter Linkedin Pin It WhatsApp You may also like 53:15 Webinar: Twice Weekly Steroids & Exercise – Study Update and Preliminary Findings (April 2022) Posted on April 13, 2022 Research & Clinical Trial Webinars, Webinars 59:37 Webinar: Carrier Cardiac Care (March 2022) Posted on April 7, 2022 Care Webinars, Research & Clinical Trial Webinars, Webinars 59:44 Webinar: Development of Imaging Biomarkers for Becker Muscular Dystrophy (March 2022) Posted on March 31, 2022 Research & Clinical Trial Webinars, Webinars 1:04:50 NIH Hosts Working Group to Better Understand Immune Response in Gene Therapy Trials Posted on March 28, 2022 Research & Clinical Trial Webinars, Webinars 48:51 Webinar: FibroGen DMD Pamrevlumab Phase 3 Clinical Studies Highlight (February 2022) Posted on February 7, 2022 Research & Clinical Trial Webinars, Webinars 59:31 Connect with the Experts: Pulmonary Care (October 2021) Posted on November 18, 2021 Care Webinars, Webinars 1:09:52 Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (October 2021) Posted on October 26, 2021 Research & Clinical Trial Webinars, Webinars 1:29:24 Connect with the Experts: Cardiac Care (September 2021) Posted on September 28, 2021 Care Webinars, Webinars 123…19»Page 1 of 19
by: Parent Project Muscular Dystrophy
